← All trials
NCT06257706
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 7, 2024
- Primary completion
- Jan 3, 2027
- Completion date
- Sep 6, 2028
- First posted
- Feb 14, 2024
- Last posted
- Aug 14, 2024
- Enrollment
- 304
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Robarts Clinical TrialsLead sponsor
- Robarts Clinical TrialsOfficial
- TakedaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.